How Is The Market Feeling About Iovance Biotherapeutics?
Portfolio Pulse from Benzinga Insights
Iovance Biotherapeutics (NYSE:IOVA) has seen an 8.92% increase in its short percent of float, now at 19.53% of all shares available for trading. This indicates a bearish market sentiment, although an increase in short interest can sometimes be bullish. The company's short interest is higher than its peer group average of 12.57%.
May 09, 2024 | 5:30 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Iovance Biotherapeutics has experienced an increase in short interest, indicating a bearish sentiment but also potential for bullish outcomes.
The increase in short interest for IOVA suggests a bearish sentiment among investors, but as the article notes, higher short interest can sometimes lead to bullish outcomes, such as a short squeeze. The exact impact on the stock price in the short term is uncertain, hence the neutral score.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100